NCT04485013 2026-02-18TTX-080 HLA-G Antagonist in Subjects With Advanced CancersTizona Therapeutics, IncPhase 1 Recruiting240 enrolled
NCT07341737 2026-01-15SL-28 for Advanced Solid TumoursSecond Life TherapeuticsPhase 1/2 Not yet recruiting60 enrolled